Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2659 (LINC02659) is a human long non-coding RNA gene, specifically classified as a long intergenic non-coding RNA (lincRNA), meaning it is longer than 200 nucleotides and does not overlap with annotated protein-coding genes[1][3]. LincRNAs are generally involved in various layers of gene regulation, such as chromatin modulation, transcriptional and post-transcriptional control, and can function with tissue specificity. However, there are currently no specific data on the molecular function, biological role, disease associations, or drug interactions for LINC02659 itself in the available reference databases or scientific literature[1]. This distinguishes it from more well-studied lincRNAs. Therefore, at this time, LINC02659 is not considered a therapeutic target or a clinically relevant biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2659 (LINC02659).